Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential

Detailed price information for Chemomab Therapeutics Ltd ADR (CMMB-Q) from The Globe and Mail including charting and trades.
Nasdaq

Chemomab (CMMB) Up on Fast Track Designation to CM-101 for PSC

Shares of Chemomab Therapeutics Ltd. CMMB were up 33.9% on Wednesday after the company announced that the FDA has granted Fast Track designation to its pipeline candidate, CM-101, for the treatment of ...

Chemomab Therapeutics Ltd. Sponsored ADR

View Chemomab Therapeutics Ltd. Sponsored ADR CMMB stock quote prices, financial information, real-time forecasts, and company news from CNN.

Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting

Detailed price information for Chemomab Therapeutics Ltd ADR (CMMB-Q) from The Globe and Mail including charting and trades.
Benzinga.com

Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise

Thursday, Chemomab Therapeutics Ltd. (NASDAQ:CMMB) released topline results from the Phase 2 SPRING trial assessing its monoclonal antibody, CM-101, in patients with primary sclerosing cholangitis ...
Nasdaq

New Analyst Forecast: $CMMB Given 'Outperform' Rating

We have seen 9 institutional investors add shares of $CMMB stock to their portfolio, and 6 decrease their positions in their most recent quarter.